Story
Growth hormone and IGF-1
Growth hormone is released by the pituitary in pulses, and the liver relays it by making IGF-1; in adulthood it mainly directs fuel during fasting. Both low and high IGF-1 are linked to higher risk of death.
Last updated
Overview and key questions
In short: Growth hormone is released by the pituitary gland at the base of the brain, but it does not flow into the blood at a steady rate; it comes out in bursts.
Educational content, not medical advice. See a clinician about your own case.
Push and brake: two signals steer the pituitary: The pituitary at the base of the brain releases growth hormone, and the hypothalamus steers it with two signals: one to release, one to stop.
Two days fasting: more bursts, bigger bursts: After a day or two of continuous fasting, the pituitary releases growth hormone in more bursts, and each burst is larger.
Story path
Chapter 1
Pulses and the liver relay
When growth hormone reaches the liver through the bloodstream, liver cells pick up the signal and make insulin-like growth factor 1 (). Mouse experiments show that removing the liver's share cuts blood IGF-1 by about three quarters. IGF-1 is also thought to loop back and hold down the pituitary, so that it does not release too much growth hormone. Tissues such as muscle, fat and kidney also make IGF-1 on the spot, and it acts right where it is made. The IGF-1 measured in blood mainly tells you how much the liver step is putting out; it is not the whole amount at work inside the tissues.
Evidence · Mice without liver IGF-1
Blood growth hormone was clearly higher in the knockout mice. The authors' explanation is that without the liver's IGF-1 pushing back, the pituitary releases more; this is an inference and was not measured directly. All of these conclusions come from mice only.
Evidence · Deep sleep and growth hormone
This is an association, not proof that deepening sleep would bring it back, and the study included only men.
Clinical · Why the lab report shows IGF-1
Blood , by contrast, is what the liver makes after it receives the growth hormone signal, so it reflects the output of this axis from the other end. How to read a result is for a doctor to judge alongside other tests.
Chapter 2
What it does in adults
Its protein-sparing effect shows up mainly during fasting: normally it has little effect on protein metabolism, but if growth hormone is missing during a fast, protein loss gets clearly worse. It also works against insulin, which keeps blood sugar from falling too low. As for building, what growth hormone pushes up is collagen in tendons and muscle, not the myofibrillar protein that makes muscles thicker.
Mechanism · Opposing insulin to guard blood sugar
There is an apparent contradiction: adults who lack growth hormone and people with acromegaly, who have too much of it, both tend toward insulin resistance. In the first group this may be tied to more fat and less lean mass, and it temporarily worsens when growth hormone treatment starts; in the second group insulin resistance persists even though they have more muscle and less fat. The relationship between growth hormone and blood sugar is neither more-is-better nor less-is-better.
Evidence · Collagen up, muscle fiber protein flat
In adults, growth hormone looks more like it is reinforcing connective tissue than directly making muscle grow.
Clinical · When it is truly lacking
Keep in mind: this applies only to people with a confirmed deficiency, and it does not mean healthy people gain more by taking more; the amount has to be set for each person, and whether to treat is for a doctor to weigh against the risks.
Chapter 3
Fasting and exercise turn it up
When a fast stretches to several days, the picture changes: growth hormone stays high, but the made by the liver goes down. Researchers think this pairing of high growth hormone and low IGF-1 may help the body keep its fuel supply going during starvation, rather than promote growth.
Exercise raises it too, and the harder the effort, the higher it goes; the rise comes from more being released per burst, not from more bursts. Still, this hormone peak after exercise does not decide how much muscle grows.
The rise in growth hormone during a fast is the body's way of managing hunger, not a goal worth fasting for; as with releaser supplements, a higher blood reading is not the point in itself.
Numbers · Two days and five days of fasting
In 1988, Ho and colleagues had 6 healthy men fast for 5 days. Compared with a fed day, the number of growth hormone pulses per day during the fast rose from about 5.8 to 9.9, and both the total over the day and the height of the biggest burst went up. IGF-1 (then called somatomedin C) fell from 1.31 on day 1 of the fast to 0.77 U/ml on day 5; at the same time blood sugar fell, and fatty acids and rose sharply. Read together: at about 56 hours of fasting IGF-1 had not changed, and by day 5 it had fallen; when in between it started to fall, neither study measured.
Both studies had only a small number of young healthy men, compared with themselves before and after, with no parallel control group; the numbers for women and older people may not be the same.
Evidence · Harder effort, bigger bursts
Pritzlaff's study had only 10 young men, measured blood for only a few hours after exercise, did not measure muscle, and did not include women or older people.
Chapter 4
Taking apart GH releaser supplements
Taken apart, the ingredients these products commonly advertise that have been studied are a few amino acids, arginine, ornithine and lysine, plus gamma-aminobutyric acid (). What is right: given by infusion or by mouth, these ingredients can raise growth hormone in the blood. What is wrong: what rises is only a hormone reading in the blood; for arginine and its relatives no properly designed trial shows more muscle or strength, and for GABA nobody has measured muscle at all. Even using real growth hormone directly gives healthy older adults only small changes in body composition, with side effects that are more common.
So: a short spike of growth hormone in the blood is not the goal; muscle, strength and metabolic health are. If you want it higher, hard training alone raises it more than taking arginine does.
Evidence · Arginine and its relatives
A 2006 randomized crossover trial by Collier and colleagues measured this in more detail: 8 healthy men received different treatments on separate days, including 7 grams of arginine alone, resistance training alone, and arginine followed by training. The authors report that arginine alone also raised growth hormone, but less than training alone; taking arginine before training actually made the exercise-driven rise smaller. The authors suggest that a pituitary just stimulated by arginine responds less to the next stimulus for a short while.
For healthy adults, the safety evidence for up to 20 grams of arginine a day is strong, and long-term safety data for higher amounts are insufficient; but amounts large enough to raise growth hormone noticeably often cause stomach upset and diarrhea. Ornithine, lysine and have no comparable safety data. The main problem with these products is that there is no evidence they help.
Evidence · GABA was only tested in the blood
But the study measured only hormone concentrations in the blood over 90 minutes, not muscle, strength or performance; the authors also acknowledge that how much this rise contributes to muscle growth is unknown. For the two other uses GABA is often promoted for, easing stress and helping sleep, the oral evidence is also limited, and even thinner for sleep.
Evidence · Healthy older adults given real GH
Those given it more often had soft-tissue swelling, joint pain, carpal tunnel syndrome and breast enlargement in men, and new diabetes and impaired fasting glucose were slightly more common too. The authors concluded that growth hormone cannot be recommended as an anti-aging therapy. Most studies were small, and some important outcomes were measured rarely or inconsistently and could not be pooled.
Chapter 5
The two faces of IGF-1
On the other side, there is a group of people in Ecuador born without working growth hormone receptors, who have almost no IGF-1 signaling. Followed for many years, they rarely got cancer and had no diabetes, yet they did not live longer because of it. In mice, turning this signal down extends lifespan; in humans, that has not been shown.
Small studies suggest that in humans, how much protein you eat may move IGF-1 more than calories do: long-term calorie restrictors who eat plenty of protein do not have lower IGF-1, while cutting protein for a few weeks brings it down. Still, several days of eating almost nothing lowers IGF-1 too.
Numbers · Death and cancer risk
In a large UK cohort of about 390,000 cancer-free participants, the higher the IGF-1, the slightly higher the risk of thyroid, breast, colorectal and prostate cancer, by less than a fifth; people with higher IGF-1, by contrast, had lower risk of ovarian and liver cancer. Average follow-up was only about 7 years, and the authors note that reverse causation cannot be ruled out, meaning early disease not yet diagnosed may have changed IGF-1 first.
In the same database, another analysis applied Mendelian randomization to about 210,000 women: it uses inborn gene variants that set IGF-1 higher or lower to infer cause, sidestepping interference from lifestyle. Women with genetically higher IGF-1 had only a slightly higher breast cancer risk; this was seen mainly in estrogen receptor-positive tumors, with no link in receptor-negative ones. The authors consider this support for a possible causal relationship, but the effect is small. The first two studies are observational associations and cannot show that IGF-1 itself causes the difference in risk.
Evidence · People with almost no IGF-1 signal
But they did not live longer: about seven in ten deaths came from causes unrelated to aging, such as seizure disorders, alcohol poisoning, accidents and liver cirrhosis. The group is small, it is a single population, and the study is observational; the protective mechanisms the paper proposes come from cell experiments in the lab.
A 2013 review by Junnila and colleagues notes that several mutations that turn down growth hormone and IGF-1 signaling make mice live longer; similar mutations have been found in humans, but whether they affect lifespan has not been established. Growth hormone has been widely promoted as an anti-aging drug, yet evidence that it works is lacking.
In practice · Protein and your IGF-1 result
So when you get a lab report: both ends of IGF-1 are linked to higher risk, and there is no lower-is-better target. When it is off, the cause may be a change in the pituitary's signal, a problem at the liver step, or recently eating little or eating little protein. IGF-1 also falls with age on its own, so it is for a doctor to judge alongside age and other tests.
References (18)
- Hartman, M. L., Veldhuis, J. D., Johnson, M. L., Lee, M. M., Alberti, K. G., Samojlik, E., & Thorner, M. O. (1992). Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. Journal of Clinical Endocrinology & Metabolism, 74(4), 757-765. 10.1210/jcem.74.4.1548337
- Van Cauter, E., Leproult, R., & Plat, L. (2000). Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA, 284(7), 861–868. 10.1001/jama.284.7.861
- Yakar, S., Liu, J.-L., Stannard, B., Butler, A., Accili, D., Sauer, B., & LeRoith, D. (1999). Normal growth and development in the absence of hepatic insulin-like growth factor I. Proceedings of the National Academy of Sciences of the United States of America, 96(13), 7324-7329. 10.1073/pnas.96.13.7324
- Møller, N., & Jørgensen, J. O. L. (2009). Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews, 30(2), 152-177. 10.1210/er.2008-0027
- Doessing, S., Heinemeier, K. M., Holm, L., Mackey, A. L., Schjerling, P., Rennie, M., Smith, K., Reitelseder, S., Kappelgaard, A.-M., Rasmussen, M. H., Flyvbjerg, A., & Kjaer, M. (2010). Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. The Journal of Physiology, 588(2), 341–351. 10.1113/jphysiol.2009.179325
- Ho, K. Y., Veldhuis, J. D., Johnson, M. L., Furlanetto, R., Evans, W. S., Alberti, K. G., & Thorner, M. O. (1988). Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. Journal of Clinical Investigation, 81(4), 968-975. 10.1172/JCI113450
- Pritzlaff, C. J., Wideman, L., Weltman, J. Y., Abbott, R. D., Gutgesell, M. E., Hartman, M. L., Veldhuis, J. D., & Weltman, A. (1999). Impact of acute exercise intensity on pulsatile growth hormone release in men. Journal of Applied Physiology, 87(2), 498–504. https://doi.org/10.1152/jappl.1999.87.2.498 10.1152/jappl.1999.87.2.498
- West, D. W. D., Burd, N. A., Tang, J. E., Moore, D. R., Staples, A. W., Holwerda, A. M., Baker, S. K., & Phillips, S. M. (2010). Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors. Journal of Applied Physiology, 108(1), 60-67. 10.1152/japplphysiol.01147.2009
- Chromiak, J. A., & Antonio, J. (2002). Use of amino acids as growth hormone-releasing agents by athletes. Nutrition, 18(7–8), 657–661. https://doi.org/10.1016/s0899-9007(02)00807-9 10.1016/s0899-9007(02)00807-9
- Powers, M. E., Yarrow, J. F., McCoy, S. C., & Borst, S. E. (2008). Growth hormone isoform responses to GABA ingestion at rest and after exercise. Medicine & Science in Sports & Exercise, 40(1), 104–110. https://doi.org/10.1249/mss.0b013e318158b518 10.1249/mss.0b013e318158b518
- Liu, H., Bravata, D. M., Olkin, I., Nayak, S., Roberts, B., Garber, A. M., & Hoffman, A. R. (2007). Systematic review: The safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine, 146(2), 104–115. https://doi.org/10.7326/0003-4819-146-2-200701160-00005 10.7326/0003-4819-146-2-200701160-00005
- Collier, S. R., Collins, E., & Kanaley, J. A. (2006). Oral arginine attenuates the growth hormone response to resistance exercise. Journal of Applied Physiology, 101(3), 848–852. https://doi.org/10.1152/japplphysiol.00285.2006 10.1152/japplphysiol.00285.2006
- Burgers, A. M. G., Biermasz, N. R., Schoones, J. W., Pereira, A. M., Renehan, A. G., Zwahlen, M., Egger, M., & Dekkers, O. M. (2011). Meta-analysis and dose-response metaregression: Circulating insulin-like growth factor I (IGF-I) and mortality. The Journal of Clinical Endocrinology & Metabolism, 96(9), 2912-2920. https://doi.org/10.1210/jc.2011-1377 10.1210/jc.2011-1377
- Knuppel, A., Fensom, G. K., Watts, E. L., Gunter, M. J., Murphy, N., Papier, K., Perez-Cornago, A., Schmidt, J. A., Smith Byrne, K., Travis, R. C., & Key, T. J. (2020). Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: Prospective analyses in UK Biobank. Cancer Research, 80(18), 4014-4021. https://doi.org/10.1158/0008-5472.CAN-20-1281 10.1158/0008-5472.CAN-20-1281
- Murphy, N., Knuppel, A., Papadimitriou, N., Martin, R. M., Tsilidis, K. K., Smith-Byrne, K., Fensom, G., Perez-Cornago, A., Travis, R. C., Key, T. J., & Gunter, M. J. (2020). Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: Observational and Mendelian randomization analyses with ~430 000 women. Annals of Oncology, 31(5), 641-649. https://doi.org/10.1016/j.annonc.2020.01.066 10.1016/j.annonc.2020.01.066
- Guevara-Aguirre, J., Balasubramanian, P., Guevara-Aguirre, M., Wei, M., Madia, F., Cheng, C.-W., Hwang, D., Martin-Montalvo, A., Saavedra, J., Ingles, S., de Cabo, R., Cohen, P., & Longo, V. D. (2011). Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine, 3(70), 70ra13. https://doi.org/10.1126/scitranslmed.3001845 10.1126/scitranslmed.3001845
- Junnila, R. K., List, E. O., Berryman, D. E., Murrey, J. W., & Kopchick, J. J. (2013). The GH/IGF-1 axis in ageing and longevity. Nature Reviews Endocrinology, 9(6), 366-376. https://doi.org/10.1038/nrendo.2013.67 10.1038/nrendo.2013.67
- Fontana, L., Weiss, E. P., Villareal, D. T., Klein, S., & Holloszy, J. O. (2008). Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell, 7(5), 681–687. https://doi.org/10.1111/j.1474-9726.2008.00417.x 10.1111/j.1474-9726.2008.00417.x
Written from the sources listed above. Checked sentence by sentence against them in . No physician reviews this site: it explains how the body works, and it is not medical advice. How we make content
Spotted an error, or something unclear? Email us. We read every message, check it against the sources, and fix what's wrong.